AFLD 2012 FFC vs Respondent M16

Facts
The French Cycling Federation (Fédération Française de Cyclisme, FFC) charges respondent M16 for a violation of the Anti-Doping Rules. During a cycling event on May 17, 2011, a sample was taken for doping test purposes. The sample tested positive for metabolites of Metandienone, Methylhexaneamine, oxandrolone and Stanozolol. Also for tuaminoheptane, prednisone, prednisolone and triamcinolone acetonide. All of these substances are prohibited according the World Anti-Doping Agency (WADA) prohibited list.

History
The respondent claims that the positive result derives from capsules he took for weightloss and the presence of triamcinolone acetonide, of prednisolone and prednisone be explained by the use of two medications to treat seasonal allergies and bronchitis which he suffers, also he used nasal drops. He has a dated medical prescription.

Decision
1. The sanction is a period of ineligibility of 3 years in which respondent can't take part of competition or manifestations from the FFC or related French sport federations.
2. The decision will start on the date of notification and will last till the end of the sanction of October 28, 2011, by the disciplinary committee of the FFC.
3. The notification will be published and sent to the parties involved.

Original document

Parameters

Legal Source
National Decisions
Date
9 February 2012
Original Source
French Anti-Doping Agency (AFLD)
Country
France
Language
French
ADRV
Adverse Analytical Finding / presence
Legal Terms
Period of ineligibility
Sport/IFs
Cycling (UCI) - International Cycling Union
Other organisations
Agence Française de Lutte contre le Dopage (AFLD) - French Anti-Doping Agency
Fédération Française de Cyclisme (FFC) - French Cycling Federation
Laboratories
Paris, France: Agence Française de Lutte contre le Dopage (AFLD)
Doping classes
S1. Anabolic Agents
S6. Stimulants
S9. Glucocorticosteroids
Substances
4-Methylhexan-2-amine (methylhexaneamine, 1,3-dimethylamylamine, 1,3 DMAA)
Metandienone (17β-hydroxy-17α-methylandrosta-1,4-dien-3-one)
Oxandrolone
Prednisolone
Prednisone
Stanozolol
Triamcinolone
Tuaminoheptane
Document type
Pdf file
Date generated
7 February 2014
Date of last modification
22 April 2021
Category
  • Legal Source
  • Education
  • Science
  • Statistics
  • History
Country & language
  • Country
  • Language
Other filters
  • ADRV
  • Legal Terms
  • Sport/IFs
  • Other organisations
  • Laboratories
  • Analytical aspects
  • Doping classes
  • Substances
  • Medical terms
  • Various
  • Version
  • Document category
  • Document type
Publication period
Origin